Ran Reshef, MD

Academic Appointments

  • Associate Professor of Medicine at CUMC

Current Administrative Positions

  • Director, Translational Research, Blood and Marrow Transplantation
  • Clinical Lead, CAR-T Cell Program

This provider accepts new patients

Appointment Phone Number: (212) 305-5098

Ran Reshef, MD

Dr. Reshef trained in Hematology, Oncology and Bone Marrow Transplantation and received a Master of Science degree in Translational Research from the University of Pennsylvania. He joined Columbia University in 2015 as Director of Translational Research for the Blood and Marrow Transplantation program. He is the Clinical Lead for the CAR-T Cell Program at Columbia, a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center.

Dr. Reshef serves as Director of Translational Research for the Blood and Marrow Transplantation program and Clinical Lead for the CAR-T Cell Program. He joined Columbia University in 2015 after spending 8 years at the University of Pennsylvania where he conducted research in stem-cell transplantation and immunotherapy. Dr. Reshef primarily cares for patients with leukemia, MDS, lymphoma, myeloma and other blood cancers and he oversees the clinical trials offered to patients undergoing stem-cell transplantation. His research focuses on innovative ways to improve the outcome of patients undergoing stem-cell transplants and novel cell therapies. Dr. Reshef's research is funded by the National Cancer Institute, American Society of Clinical Oncology, National Marrow Donor Program and Department of Defense. He previously received awards from the Leukemia & Lymphoma Society and American Society of Hematology.

Areas of Expertise

  • Blood and Marrow Stem Cell Transplantation
  • Hematology/Oncology
  • Amyloidosis
  • Bone Marrow Transplant
  • Cancer Immunotherapy
  • Cellular Therapy
  • Leukemia
  • Lymphoma
  • Multiple Myeloma

Languages Spoken

  • Hebrew

Education and Training

  • MD, 2003 Medicine, Sackler School of Medicine, Tel Aviv University (Israel)
  • MSc, 2011 Translational Research, Perelman School of Medicine University of Pennsylvania
  • Internship: 1998 Tel Aviv Sourasky Medical Center, Israel
  • Residency: 2007 Tel Aviv Sourasky Medical Center, Israel
  • Fellowship: 2009 Perelman School of Medicine University of Pennsylvania


  • William Black Building

    650 West 168th Street
    New York, NY 10032
    (212) 342 0530
  • CUMC/Herbert Irving Pavilion

    161 Fort Washington Avenue
    New York, NY 10032
    For new and current patient appointments, call:
    (212) 305-5098
    (212) 305-8111

Provider Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Insurance Programs

Please contact the provider's office directly to verify that your particular insurance is accepted.

  • Aetna [EPO, HMO, Medicare Managed Care, NYP Employee Plan, NY Signature, POS, PPO, Signature Administrators, Student Health]
  • Affinity [Essential Plan, Medicaid Managed Care]
  • AgeWell [Medicare Managed Care, Special Needs Plan]
  • Amida Care [Special Needs Plan]
  • Capital District Physician Health Plan [Capital District Physician Health Plan]
  • Cigna [EPO, Great West, HMO, POS, PPO]
  • Emblem/GHI [Medicare Managed Care, PPO]
  • Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
  • Empire Blue Cross/Blue Shield [EPO, Medicare Managed Care, PPO]
  • Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
  • Fidelis Care [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
  • Healthfirst [Child/Family Health Plus, Leaf (Exchange), Medicaid Managed Care, Medicare Managed Care]
  • Local 1199 [Local 1199]
  • MagnaCare [MagnaCare]
  • Multiplan [Multiplan]
  • MVP Health Care [Child/Family Health Plus, Essential Plan, HMO, Medicaid Managed Care]
  • Oxford Health Plans [Freedom, Liberty]
  • UnitedHealthcare [Columbia University Employee Plan, Compass (Exchange), HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]
  • VNSNY CHOICE [Medicare Managed Care, SelectHealth, Special Needs Plan]
  • WellCare [Medicaid Managed Care, Medicare Managed Care]

Contact Info

  • (212) 342-0530


CAR-T Cells Meet Myeloma - Myeloma Crowd NY May 2018

CAR T-Cell Therapy: What We Know (and Don’t Know) 1 Year Later - Association of American Cancer Centers

Committees / Societies / Memberships

American Society of Clinical Oncology

American Society of Hematology

American Society of Blood and Marrow Transplantation

Center for International Blood and Marrow Transplant Research

Bone Marrow Transplant Clinical Trials Network Steering Committee

Mount Sinai Acute GvHD International Consortium

American Journal of Hematology (Editorial Board)

National Institues of Health (Study Section)

Department of Defense (Study Section)

Honors and Awards

  • Sternberg Research Award, Abramson Cancer Center, University of Pennsylvania (2008)
  • Bradley Fellow Research Award, Department of Medicine, University of Pennsylvania (2011)
  • Austrian Junior Faculty Award, Department of Medicine, University of Pennsylvania (2012)
  • Amy Strelzer Manasevit Award for the Study of Post-Transplant Complications, National Marrow Donor Program (2013)


  1. Reshef R, Luger SM, Hexner EO, Loren AW, Frey NV, Nasta, SD, Goldstein SC, Stadtmauer EA, Smith J, Bailey S, Mick R, Heitjan DF, Emerson SG, Hoxie J, Vonderheide RH, Porter DL (2012). "Effect of Blocking Lymphocyte Chemotaxis on Visceral Graft-vs-Host Disease." N Engl J Med 367:135-145
  2. Reshef R, Huffman AP, Gao A, Luskin MR, Hexner EO, Loren AW, Frey NV, Stadtmauer EA, Luger SM, Mangan JK, Nasta SD, Gill SI, Sell M, Kambayashi T, Richman LP, Vonderheide RH, Mick R, Porter DL (2015). "High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection In Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning" J Clin Oncol 33:2392-2398.
  3. Ryan H. Moy, Austin P. Huffman, Lee P. Richman, Lisa Crisalli, Ximi K. Wang, James A. Hoxie, Rosemarie Mick, Stephen G. Emerson, Yi Zhang, Robert H. Vonderheide, David L. Porter and Ran Reshef (2017) "Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis" Blood 129:906-916
  4. Mishkin AD, Mapara MY, Reshef R (2018). "Iatrogenic Infertility After Curative Stem Cell Transplantation in Sickle Cell Disease Patients". Ann Intern Med 2018 Jun 19;168(12):881-88

For a complete list of publications, please visit PubMed.gov